Jennifer Taubert

Currently holds a position at Johnson & Johnson

2.6

2.6

Position	Company	Period
Executive Vice President - Worldwide Chairman, Pharmaceuticals	Johnson & Johnson	July 2, 2018 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2025-09-05	2025-09-04	Johnson & Johnson (JNJ)	S Sale	86,866 -6.6% 26.17 US$3,510,107	86,866 -6.6%	26.17	US$3,510,107
2025-09-04	2025-09-04	Johnson & Johnson (JNJ)	PrS Proposed sale	90,401 325.94 US$3,772,690	90,401	325.94	US$3,772,690
2024-02-12	2024-02-09	Johnson & Johnson (JNJ)	S Sale	43,670 +39.5% 420.55 US$4,984,218	43,670 +39.5%	420.55	US$4,984,218
2024-02-09	2024-02-09	Johnson & Johnson (JNJ)	PrS Proposed sale	59,397 156.25 US$9,280,528	59,397	156.25	US$9,280,528
2022-11-23	2022-11-22	Johnson & Johnson (JNJ)	S Sale	76,923 -37.8% 176.78 US$13,598,402	76,923 -37.8%	176.78	US$13,598,402